Can Clot-Busting drugs help minor stroke patients? major study aims to find out
NCT ID NCT07322835
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This large study in China will follow 5,400 people with minor ischemic stroke to see if clot-busting drugs or mechanical clot removal (reperfusion therapy) leads to better recovery than standard medications. Participants are treated based on their doctor's choice, and researchers will compare outcomes like disability and bleeding risk at 90 days. The goal is to provide real-world evidence to guide treatment decisions for minor strokes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- reperfusion therapy (intravenous thrombolysis and/or endovascular intervention)
- What this could lead to
- If successful, this study could clarify whether clot-busting drugs or mechanical clot removal help people with minor strokes recover better than standard medications alone.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be less definitive. The study is still recruiting, and outcomes depend on real-world treatment choices, which can vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MINOR ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, 510080, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.